LCN2 and acute kidney injury: Of the two markers investigated in the present study, only P-NGAL was associated with renal replacement therapy and AKI assessed by changes in cystatin C plasma concentrations, suggesting P-NGAL may be a more robust indicator of AKI and other renal outcomes.